Latest news releases from NIH-funded organizations

Funded Research News

Updates every hour. Last Updated: 22-Apr-2025 02:08 ET (22-Apr-2025 06:08 GMT/UTC)

17-Apr-2025

Cerebral palsy medications given to adults may not match needs

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

Some medications are seen as a "fix-all" solution, not addressing the root problem

Journal

Mayo Clinic Proceedings

Funder

NIH/National Institutes of Health

17-Apr-2025

Link between dementia and air pollution drives research collaboration

University of California - Merced

There is no shortage of data linking air pollution to an array of health problems, especially for those who work outdoors. A group of researchers, led by UC Merced geosciences Professor Xuan Zhang, are examining the specific pollutants associated with Lewy body dementia and their underlying mechanisms.

Funder

NIH/National Institute of Environmental Health Sciences

16-Apr-2025

DNA organization offers clues for advancing stem cell therapy

University of California - Riverside
Peer-Reviewed Publication

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Journal

Genes & Development

Funder

NIH/National Institute of General Medical Sciences, University of California Office of the President, California Institute for Regenerative Medicine

16-Apr-2025

Golden eyes: How gold nanoparticles may one day help to restore people’s vision

Brown University
Peer-Reviewed Publication

A team of Brown University researchers has identified a promising new approach that may one day help to restore vision in people affected by macular degeneration and other retinal disorders.

Journal

ACS Nano

Funder

NIH/National Institutes of Health

16-Apr-2025

Reprogramming cancer cells to treat an aggressive type of leukemia

Ludwig Institute for Cancer Research
Peer-Reviewed Publication

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Journal

Nature

Funder

Ludwig Cancer Research, NIH/National Institutes of Health, Academy of Finland, Cancer Foundation Finland, Sigrid Jusélius Foundation, National Institute for Health Research, NIHR Oxford Biomedical Research Centre, Cancer Research UK